BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 870336)

  • 1. Effects of tranylcypromine and pargyline on brain tryptamine.
    Tabakoff B; Moses F; Philips SR; Boulton AA
    Experientia; 1977 Mar; 33(3):380-1. PubMed ID: 870336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time studies on the effects of tranylcypromine plus tryptophan on formation of tryptamine and 5-hydroxytryptamine in rat brain.
    Hay JL; McKim HR; Baker GB; Dewhurst WG
    Proc West Pharmacol Soc; 1982; 25():133-5. PubMed ID: 7122487
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of tranylcypromine and pargyline on indoleamines in brain.
    Tabakoff B; Moses F
    Biochem Pharmacol; 1976 Dec; 25(23):2555-60. PubMed ID: 985576
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
    Luscombe G; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Jun; 32(12):1857-64. PubMed ID: 6192824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tranylcypromine on the concentration of some trace amines in the diencephalon and hippocampus of the rat.
    Philips SR; Baker GB; McKim HR
    Experientia; 1980 Feb; 36(2):241-2. PubMed ID: 7371771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
    Denys A; Levy J; Michel-Ber E
    Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A; Costa E
    Biochem Pharmacol; 1975 Sep; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 11. The distribution and turnover of tryptamine in the brain and spinal cord.
    Juorio AV; Durden DA
    Neurochem Res; 1984 Sep; 9(9):1283-93. PubMed ID: 6504238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan.
    Marsden CA; Curzon G
    Neuropharmacology; 1979 Feb; 18(2):159-64. PubMed ID: 431783
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of caffeine on mouse striatal tryptamine.
    Juorio AV
    Eur J Pharmacol; 1985 Dec; 119(3):235-7. PubMed ID: 2419142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.
    Marsden CA; Curzon G
    Psychopharmacology (Berl); 1978 Apr; 57(1):71-6. PubMed ID: 149328
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 16. Tranylcypromine: effects on norepinephrine metabolism in rat brain.
    Schildkraut JJ
    Am J Psychiatry; 1970 Jan; 126(7):925-31. PubMed ID: 5409564
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tryptamine in the behavioural changes caused by a monoamine oxidase inhibitor and L-tryptophan [proceedings].
    Curzon G; Marsden CA
    Br J Pharmacol; 1977 Jun; 60(2):307P-308P. PubMed ID: 880472
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of some antipsychotic drugs, D-amphetamine, and reserpine on the concentration and rate of accumulation of tryptamine and 5-hydroxytryptamine in the mouse striatum.
    Juorio AV
    Can J Physiol Pharmacol; 1982 Mar; 60(3):376-80. PubMed ID: 6122494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.